Cargando…

Initial experience with the novel p64MW HPC flow diverter from a cohort study in unruptured anterior circulation aneurysms under dual antiplatelet medication

OBJECTIVE: p64MW HPC is a new low-profile flow diverter with reduced thrombogenicity due to hydrophilic coating. The purpose of this study was to evaluate its safety and efficacy in Mongolian patients under dual antiplatelet therapy. METHODS: Consecutive patients with unruptured anterior circulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrov, Andrey, Rentsenkhuu, Ganbaatar, Nota, Baatarjan, Ganzorig, Erdenebat, Regzengombo, Boldbat, Jagusch, Sara, Henkes, Elina, Henkes, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874381/
https://www.ncbi.nlm.nih.gov/pubmed/32640858
http://dx.doi.org/10.1177/1591019920939845